Anchor Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.98K | Hold |
40
| – | – | ﹤0.01% | 831 |
|
|
2025
Q4 | $9.63K | Hold |
40
| – | – | ﹤0.01% | 817 |
|
|
2025
Q3 | $10.9K | Hold |
40
| – | – | ﹤0.01% | 801 |
|
|
2025
Q2 | $10.3K | Hold |
40
| – | – | ﹤0.01% | 794 |
|
|
2025
Q1 | $8.95K | Hold |
40
| – | – | ﹤0.01% | 810 |
|
|
2024
Q4 | $9.15K | Hold |
40
| – | – | ﹤0.01% | 808 |
|
|
2024
Q3 | $9.77K | Hold |
40
| – | – | ﹤0.01% | 789 |
|
|
2024
Q2 | $7.66K | Hold |
40
| – | – | ﹤0.01% | 786 |
|
|
2024
Q1 | $7.92K | Buy |
+40
| New | +$7.33K | ﹤0.01% | 814 |
|
|
2023
Q2 | – | Sell |
-50
| Closed | -$10.9K | – | 995 |
|
|
2023
Q1 | $10.9K | Hold |
50
| – | – | ﹤0.01% | 730 |
|
|
2022
Q4 | $10.4K | Hold |
50
| – | – | ﹤0.01% | 713 |
|
|
2022
Q3 | $10.9K | Sell |
50
-500
| -91% | -$114K | ﹤0.01% | 705 |
|
|
2022
Q2 | $115K | Sell |
550
-35
| -6% | -$7.45K | 0.02% | 434 |
|
|
2022
Q1 | $142K | Sell |
585
-100
| -15% | -$24.2K | 0.02% | 422 |
|
|
2021
Q4 | $178K | Hold |
685
| – | – | 0.02% | 396 |
|
|
2021
Q3 | $181K | Sell |
685
-50
| -7% | -$13.7K | 0.03% | 369 |
|
|
2021
Q2 | $181K | Hold |
735
| – | – | 0.03% | 377 |
|
|
2021
Q1 | $143K | Buy |
735
+585
| +390% | +$117K | 0.02% | 388 |
|
|
2020
Q4 | $31.9K | Hold |
150
| – | – | 0.01% | 533 |
|
|
2020
Q3 | $25.7K | Buy |
150
+50
| +50% | +$9.23K | 0.01% | 532 |
|
|
2020
Q2 | $19.2K | Hold |
100
| – | – | ﹤0.01% | 559 |
|
|
2020
Q1 | $14.7K | Hold |
100
| – | – | ﹤0.01% | 577 |
|
|
2019
Q4 | $15.5K | Hold |
100
| – | – | ﹤0.01% | 603 |
|
|
2019
Q3 | $13.5K | Hold |
100
| – | – | ﹤0.01% | 609 |
|
|
2019
Q2 | $12.2K | Hold |
100
| – | – | ﹤0.01% | 614 |
|
|
2019
Q1 | $10.4K | Hold |
100
| – | – | ﹤0.01% | 617 |
|
|
2018
Q4 | $11.4K | Hold |
100
| – | – | ﹤0.01% | 605 |
|
|
2018
Q3 | $11.5K | Hold |
100
| – | – | ﹤0.01% | 633 |
|
|
2018
Q2 | $10.4K | Hold |
100
| – | – | ﹤0.01% | 650 |
|
|
2018
Q1 | $9.85K | Hold |
100
| – | – | ﹤0.01% | 636 |
|
|
2017
Q4 | $8.47K | Hold |
100
| – | – | ﹤0.01% | 660 |
|
|
2017
Q3 | $7.7K | Buy |
+100
| New | +$7.65K | ﹤0.01% | 653 |
|
|
2017
Q1 | – | Sell |
-1,710
| Closed | -$106K | – | 707 |
|
|
2016
Q4 | $106K | Hold |
1,710
| – | – | 0.04% | 302 |
|
|
2016
Q3 | $111K | Sell |
1,710
-35
| -2% | -$2.33K | 0.04% | 284 |
|
|
2016
Q2 | $110K | Sell |
1,745
-100
| -5% | -$5.89K | 0.04% | 278 |
|
|
2016
Q1 | $107K | Buy |
+1,845
| New | +$104K | 0.04% | 275 |
|
Other funds holding RMD
VCM
VPM
DAM
Anchor Investment Management's RMD Position: Q1 2026 in Review
Anchor Investment Management held its ResMed (RMD) position steady in Q1 2026 at 40 shares worth $8.98K. The position accounts for ﹤0.01% of the portfolio, ranked #831.
Anchor Investment Management first reported a position in RMD in Q1 2016 and has held it in 36 quarters since. The position peaked at $181K in Q2 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Anchor Investment Management held 40 shares of ResMed worth $8.98K as of Q1 2026.
- Anchor Investment Management left its ResMed share count unchanged in Q1 2026.
- ResMed made up ﹤0.01% of Anchor Investment Management's portfolio in Q1 2026, its #831 holding.
- Anchor Investment Management first reported a position in ResMed in Q1 2016 and has held it in 36 quarters since.
- Anchor Investment Management's ResMed position peaked at $181K in Q2 2021.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.